Neuland Laboratories informs about outcome of board meeting

22 Nov 2017 Evaluate

Neuland Laboratories has informed about the Board of Directors at their meeting held on November 22, 2017, has approved the Unaudited financial results and limited review report by the auditors for the quarter ended September 30, 2017; and the appointment of Amit Agarwal as the Chief Financial officer (CFO) of the Company in place of D. Saharsh Rao with effect from November 22, 2017.  D.Saharsh Rao shall continue in his role as the Joint Managing Director of the Company.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

13712.60 266.60 (1.98%)
27-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1861.70
Dr. Reddys Lab 1389.35
Cipla 1506.15
Lupin 2228.00
Zydus Lifesciences 972.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.